Quick-Release Bromocriptine for Treatment of Type 2 Diabetes

E-ISSN： 1875-5704|8|5|511-516

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.8, Iss.5, 2011-09, pp. : 511-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A quick-release formulation of bromocriptine [Cycloset] appears to be a promising new treatment modality for type 2 diabetes mellitus (T2DM)

Inpharma, Vol. 1, Iss. 1655, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes

By Scranton Richard Cincotta Anthony

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 269-279

Informa Healthcare

Access to resources Recommend Favorite

Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes

By Cincotta A.H. Meier A.H. Cincotta M.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1683-1707

Informa Healthcare

Access to resources Recommend Favorite

Metformin extended release for the treatment of Type 2 diabetes mellitus

By Schwartz Sherwyn L Wu Jacqueline F Berner Bret

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 803-809

Informa Healthcare

Access to resources Recommend Favorite

Dapagliflozin for the treatment of type 2 diabetes

By Abdul-Ghani Muhammad A DeFronzo Ralph A

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1695-1703

Informa Healthcare

Access to resources Recommend Favorite